Health
Investigators identify a metabolic weak point in exhausted immune cells in head and neck cancer
Immune cells can reach head and neck tumors, but once there, many stop functioning.
Summary
Immune cells can reach head and neck tumors, but once there, many stop functioning. This helps explain why immunotherapy with immune checkpoint inhibitors—which have transformed treatment for some cancers—benefits only 17%–23% of patients with head and neck squamous cell carcinoma. These are cancers that arise from cells lining the mouth, throat and voice box.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Feeling sick may reflect widespread changes in brain activity, mouse study suggestsContinue reading
- A deadly fungus may not live to see the last of usContinue reading
- Wearable stroke rehabilitation device gives patients the upper handContinue reading
- Call for the WHO to declare the climate crisis a public health emergency of international concernContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow